Help
RSS
API
Feed
Maltego
Contact
Domain > www.elelyso.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-03-25
172.64.150.250
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Sun, 20 Oct 2024 14:20:33 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Sun, 20 Oct 2024 15:20:33 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sun, 20 Oct 2024 14:20:33 GMTContent-Type: text/htmlTransfer-Encoding: chunkedConnection: keep-aliveCF-Ray: 8d59a6365ccfef67-PDXCF-Cache-Status: HITAccept-Ranges: bytesAge: 71640C !doctype html>html langen>head> meta contentieedge http-equivx-ua-compatible> meta nameviewport contentwidthdevice-width, initial-scale1.0> meta charsetutf-8> title>ELELYSO® (taliglucerase alfa) for injection | Risk Info/title> script typetext/javascript> var pageAnalytics { pageType: null, referringUrl: , language: null, currencyCode: USD, primaryMessageCategory: null, pageSource: null, contentOrigin: null, contentID: page/c958a198-2f2f-4e77-8328-722266fd4959, country: United States, GCMA-ID: ELMigration2020, GCMA-page-ID: , trackingCode: , platform: Canvas, sessionID: , siteName: , pageName: , pageURL: , onetag: false, brand: ELELYSO, indication: Gaucher Disease, audienceType: Patient, audienceSpecialty: Patients, businessUnit: RARE DISEASE, contentType: Website, therapeuticArea: No Therapeutic Area, region: Americas, pfizerRegion: NA}; window.pfAnalyticsData { pfPage: pageAnalytics }; /script> script typetext/javascript> window.wbOnDomLoaded (() > { const callbacks ; const runAllCallbacks () > callbacks.forEach(callback > callback()); let isDomLoaded false; document.addEventListener(DOMContentLoaded, () > { isDomLoaded true; runAllCallbacks(); }); return { run: callback > isDomLoaded ? callback() : callbacks.push(callback) }; })(); /script> link relcanonical hrefhttps://elelyso.com /> meta namedescription contentLearn about a long-term ERT prescription treatment for Type 1 Gaucher disease. See risks and benefits of ELELYSO® (taliglucerase alfa) for injection. /> meta namekeywords content /> meta nameabstract content /> meta namelanguage contenten />
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]